Biotech News Summary: Most advancing and declining

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz

Biotech News Summary: Most advancing and declining stocks

Posted by on Jan 18, 2013

Biotech stocks were down on Thursday, led by Celsion Corporation (NASDAQ:CLSN) with a fall of 9.75% after Brean Capital downgraded the stock to sell from buy and reduced its price target from $7 to $1.

Theravance Inc (NASDAQ:THRX) tumbled 7.81% after pricing public offering convertible subordinated debt offering.

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) plunged 6.28% on pricing stock offering at $7.50 per share.

Amicus Therapeutics, Inc. (NASDAQ:FOLD) extended fall after Portfolio Grader recommended selling the FOLD stock.

VIVUS, Inc. (NASDAQ:VVUS) lost 4.19% after Brean Capital downgraded the stock to sell from hold.
InterMune, Inc. (NASDAQ:ITMN) declined 3.66% on pricing public offering of debt and common stock at $9.90 per share. JMP Securities has recently raised the stock from a market perform rating to an outperform rating.

Hemispherx BioPharma, Inc (NYSEAMEX:HEB) fell 3.08% after Robbins Arroyo LLP and Levi & Korsinsky filed class action lawsuits against the company.

Galena Biopharma Inc (NASDAQ:GALE) faced fourth decline in a row.

Sarepta Therapeutics Inc (NASDAQ:SRPT) retreated 2.75% after Wedbush trimmed the price target from USD 70.00 to USD 60.00 on the stock, reaffirming an outperform rating.

Sequenom, Inc. (NASDAQ:SQNM) trended down after Portfolio Grader recommended selling the stock.

Dendreon Corporation (NASDAQ NDN) turned red while Nektar Therapeutics (NASDAQ:NKTR) extended fall, both ended 2.25% down on Thursday.

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) continued to fall after disclosing plans to offer 4.4 million shares.

Despite hitting new high yesterday, Celgene Corporation (NASDAQ:CELG) edged down followed by Amgen, Inc. (NASDAQ:AMGN), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Exelixis, Inc. (NASDAQ:EXEL).

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) traded below average-volume while CEL-SCI Corporation (NYSEAMEX:CVM) traded above average-volume.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was the most active stock in the industry but showed no change by the end of trade on Thursday. Peregrine Pharmaceuticals (NASDAQ PHM) also experienced no change on below-average volume.

On the upside, NuPathe Inc (NASDAQ ATH) was the biggest gainer among biotech companies after its Zecuity was approved by the FDA for the acute treatment of Migraine.

Inovio Pharmaceuticals, Inc. (NYSEAMEX:INO) rose 7.42% on Thursday. Same day, Piper Jaffray analysts initiated coverage on the stock with an overweight rating.

Pacific Biosciences of California (NASDAQ ACB) extended three-day winning streak after Maxim Group lifted its price target from $3.00 to $4.00 on the stock.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) continued to trade near highs yesterday, ending the day up 2.37%.

Incyte Corporation (NASDAQ:INCY) rose 1.6% after analysts at Zacks reiterated their neutral rating.

Biogen Idec Inc. (NASDAQ:BIIB) was up a day after the company and Elan (NYSE:ELN) stated that that they have filed for regulatory approval to increase the use of multiple sclerosis drug Tysabri with the FDA and the European Medicines Agency.

More among biotech gainers were Illumina, Inc. (NASDAQ:ILMN), Zalicus Inc (NASDAQ:ZLCS), Cell Therapeutics Inc (NASDAQ:CTIC) and Gilead Sciences, Inc. (NASDAQ:GILD).

I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 4

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
High-Grade Copper Spurs Optimism for PolarX in Alaska

Updated Category News Views 4

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 4

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 11

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
QuickFi Nabs Top Finovate Award for Fourth Time

Updated Category News Views 5

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 3

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
2026 Buy-Side Index Reveals State Market Variance

Updated Category News Views 6

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 7

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 5

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading

Top 5 Most Recently Viewed Articles

Promising Results from CRISPR Therapeutics in Blood Cancer Trials

Updated Category News Views 126

Updates from CRISPR Therapeutics AG on Breakthrough Therapies CRISPR Therapeutics AG (NASDAQ: CRSP) has recently shared impressive updates regarding zugocaptagene geleucel (zugo-cel), a promising investigational CAR T therapy designed to target CD19. This therapy is currently under development for various hematologic malignancies and autoimmune diseases. As new clinical...

Continue Reading
Analyzing Recent Trends in GATX's Short Interest Dynamics

Updated Category News Views 123

Understanding GATX's Short Interest Trends GATX Corporation (NYSE: GATX) has witnessed a notable increase in its short interest, which has risen by 15.74% since the last reporting period. This increase indicates that there are currently around 1.25 million shares sold short, representing 6.03% of all available shares for trading. Given the company's average trading...

Continue Reading
InterDigital's Innovations in Immersive Sports Technology

Updated Category News Views 160

InterDigital to Showcase Game-Changing Technologies InterDigital, Inc. (NASDAQ: IDCC), known for its cutting-edge mobile, video, and AI technology innovations, is set to reveal exciting developments in immersive media technologies at an upcoming major conference. Bill Redmann, the Director of Standards for Immersive Media Technologies, will play a pivotal role during the...

Continue Reading
Deadline for SelectQuote Investors Approaching Soon

Updated Category News Views 167

Investors Urged to Take Action on SelectQuote Losses Attention investors! If you have experienced financial losses in SelectQuote, now is the time to act. Faruqi & Faruqi, LLP is leading the charge in investigating claims on behalf of investors who may have suffered due to the company's recent developments. Investors are proudly encouraged to reach out if they believe...

Continue Reading
Understanding Recent Options Activities for Constellation Energy

Updated Category News Views 183

The Buzz Around Constellation Energy's Options Recently, there has been a noticeable increase in bullish behavior towards Constellation Energy, particularly observed through their options trading strategies. Our thorough assessment of the options trade history for Constellation Energy Corp (NASDAQ: CEG) has unveiled a remarkable trend: an impressive 55 unusual trades were...

Continue Reading